Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia Olga Sanchez-Pernaute; Fredeswinda I. Romero-Bueno; Albert Selva-O¿Callaghan;

Real-world Effectiveness and Safety of JAK Inhibitors in Rheumatoid Arthritis: A Single-centre Study Roxana González Mazarío; Jorge Juan Fragío Gil; José Ivorra Cortés; Elena Grau García; Antonio José Cañada Martínez; Luis González Puig; Rosa María Negueroles Albuixech; José Andrés Román Ivorra;

Opciones terapéuticas en el manejo de la COVID-19 grave: una perspectiva de Reumatología Claudia Mendoza-Pinto; Mario García-Carrasco; Pamela Munguía Realpozo; Socorro Méndez-Martínez;